| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.068 | 0.03 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.03 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.04 |